Chemoinformaics analysis of Ethyl 9-heptadecenoate
| Molecular Weight | 410.419 | nRot | 7 |
| Heavy Atom Molecular Weight | 384.211 | nRig | 15 |
| Exact Molecular Weight | 410.158 | nRing | 2 |
| Solubility: LogS | -1.693 | nHRing | 0 |
| Solubility: LogP | 1.865 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 57.9546 |
| nHD | 5 | BPOL | 31.2914 |
| QED | 0.188 |
| Synth | 3.906 |
| Natural Product Likeliness | 1.865 |
| NR-PPAR-gamma | 0.398 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.995 |
| HIA | 0.681 |
| CACO-2 | -5.896 |
| MDCK | 0.0000314 |
| BBB | 0.3 |
| PPB | 0.915629 |
| VDSS | 1.696 |
| FU | 0.0772091 |
| CYP1A2-inh | 0.197 |
| CYP1A2-sub | 0.088 |
| CYP2c19-inh | 0.141 |
| CYP2c19-sub | 0.081 |
| CYP2c9-inh | 0.537 |
| CYP2c9-sub | 0.862 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.168 |
| CYP3a4-inh | 0.4 |
| CYP3a4-sub | 0.128 |
| CL | 10.519 |
| T12 | 0.885 |
| hERG | 0.174 |
| Ames | 0.219 |
| ROA | 0.05 |
| SkinSen | 0.608 |
| Carcinogencity | 0.23 |
| EI | 0.023 |
| Respiratory | 0.055 |
| NR-Aromatase | 0.887 |
| Antiviral | Yes |
| Prediction | 0.653025 |